14.20
price up icon2.23%   0.31
after-market Dopo l'orario di chiusura: 14.21 0.01 +0.07%
loading

Telix Pharmaceuticals Ltd Adr Borsa (TLX) Ultime notizie

pulisher
Jul 25, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Telix Pharmaceuticals Limited (TLX) Investors to Inquire about Securities Investigation - ACCESS Newswire

Jul 25, 2025
pulisher
Jul 23, 2025

Telix Pharma slides 10% on SEC probe into cancer treatment - Investing.com

Jul 23, 2025
pulisher
Jul 22, 2025

Telix Earnings Report: $204M Revenue Crushes Estimates as New Drug Launch Boosts Growth - Stock Titan

Jul 22, 2025
pulisher
Jul 09, 2025

Medicare Grants Crucial Reimbursement Code for Telix's Next-Gen Prostate Cancer Imaging Agent - Stock Titan

Jul 09, 2025
pulisher
Jul 03, 2025

H.C. Wainwright initiates Telix Pharmaceuticals stock with Buy rating on radiotherapy portfolio - Investing.com

Jul 03, 2025
pulisher
Jun 23, 2025

FDA Approval: Illuccix Expansion Could Add 20,000 Annual Prostate Cancer Scans - Stock Titan

Jun 23, 2025
pulisher
Jun 20, 2025

Revolutionary Dual-Isotope Cancer Imaging: Telix Unveils AlFluor Platform with Phase 3 Trial Success - Stock Titan

Jun 20, 2025
pulisher
Jun 11, 2025

Revolutionary PSMA-PET Imaging Agent Gozellix Transforms Prostate Cancer Detection Across United States - Stock Titan

Jun 11, 2025
pulisher
Jun 03, 2025

Leading Cancer Experts Reveal Future of Radiopharmaceuticals at Telix NYC Investor Day - Stock Titan

Jun 03, 2025
pulisher
May 26, 2025

5 of the best ASX 200 shares to buy in June - The Motley Fool Australia

May 26, 2025
pulisher
May 22, 2025

Telix Leaders Reveal Next-Gen Radiopharmaceutical Pipeline at Exclusive NYC Investor Day - Stock Titan

May 22, 2025
pulisher
May 14, 2025

Radiopharmaceuticals Market Products and Applications Report 2025 | SPECT Radiopharmaceuticals Lead Diagnostic Market with 67% Share - GlobeNewswire Inc.

May 14, 2025
pulisher
May 07, 2025

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy - Stock Titan

May 07, 2025
pulisher
Apr 28, 2025

Major Breakthrough: France Grants Approval for Advanced Prostate Cancer Detection Technology - Stock Titan

Apr 28, 2025
pulisher
Apr 22, 2025

Telix Delivers Record $186M Q1 Revenue as New FDA-Approved Cancer Imaging Agent Bolsters Portfolio - Stock Titan

Apr 22, 2025
pulisher
Apr 15, 2025

Breakthrough Brain Cancer Treatment Doubles Survival Time: Phase 2 Results Revealed - Stock Titan

Apr 15, 2025
pulisher
Apr 08, 2025

Telix's Groundbreaking Prostate Cancer Imaging Tech Secures Nationwide Distribution Network - Stock Titan

Apr 08, 2025
pulisher
Apr 07, 2025

Telix Pharmaceuticals appoints new CTO - Investing.com

Apr 07, 2025
pulisher
Apr 03, 2025

Major Board Addition: Ex-GSK and Sanofi Leader Joins Telix Pharmaceuticals - Stock Titan

Apr 03, 2025
pulisher
Apr 01, 2025

Revolutionary Cancer Diagnostic Begins Human Trials: First Patient Receives Novel Sarcoma Imaging Agent - Stock Titan

Apr 01, 2025
pulisher
Mar 21, 2025

FDA Green Lights Revolutionary Prostate Cancer Detection Tool: What Makes Gozellix a Game-Changer - StockTitan

Mar 21, 2025
pulisher
Mar 20, 2025

Telix Pharmaceuticals Limited (ASX:TLX) Receives FDA Approval for Gozellix® - The Capital Club

Mar 20, 2025
pulisher
Mar 20, 2025

Paladin Energy Ltd (ASX:PDN) Suspends Operations at Langer Heinrich Mine - The Capital Club

Mar 20, 2025
pulisher
Mar 17, 2025

Major Breakthrough: First PSMA-PET Imaging Agent Approved in Brazil's $330M Market - StockTitan

Mar 17, 2025
pulisher
Mar 12, 2025

Telix's Game-Changing Isotope Technology Revolutionizes Cancer Treatment Production - StockTitan

Mar 12, 2025
pulisher
Mar 03, 2025

Can Telix's Cancer Therapies Transform Urology Treatment? Top Oncologists Weigh In - StockTitan

Mar 03, 2025
pulisher
Feb 25, 2025

Could This New Kidney Cancer Imaging Tool Transform Diagnosis? FDA Fast-Tracks Review - StockTitan

Feb 25, 2025
pulisher
Feb 25, 2025

Could This New Prostate Cancer Treatment Change Patient Outcomes? Miami Trial Now Recruiting - StockTitan

Feb 25, 2025
pulisher
Feb 25, 2025

特斯拉將收購德國Manz部分資產 增強德國自動化實力 - Yahoo 財經

Feb 25, 2025
pulisher
Feb 24, 2025

〈強茂展望〉擴大海外布局 越南廠最快2026年量產 - Yahoo 財經

Feb 24, 2025
pulisher
Feb 21, 2025

Telix Pharmaceuticals Ltd (TLPPF) (FY 2024) Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada

Feb 21, 2025
pulisher
Feb 20, 2025

Can Telix's Triple Product Launch in 2025 Justify Its Bold $1.2B Revenue Target? - StockTitan

Feb 20, 2025
pulisher
Feb 19, 2025

特朗普:或將DOGE所節省開支的20%歸還予美國納稅人 - Yahoo 財經

Feb 19, 2025
pulisher
Feb 14, 2025

港股美國預託證券與本港收市比較個別發展 - Yahoo 財經

Feb 14, 2025
pulisher
Feb 13, 2025

據報匯控最快下周啟動投行部門新一輪裁員 由亞洲開始 - Yahoo 財經

Feb 13, 2025
pulisher
Feb 13, 2025

Clinical Trial Success: Telix's Revolutionary Prostate Cancer Treatment Shows Promising Results - StockTitan

Feb 13, 2025
pulisher
Feb 12, 2025

Major Breakthrough: Revolutionary Prostate Cancer Detection Tool Gets UK Green Light - StockTitan

Feb 12, 2025
pulisher
Feb 11, 2025

《業績》可口可樂(KO.US)上季盈收勝預期 受惠價格上升9% - Yahoo 財經

Feb 11, 2025
pulisher
Feb 03, 2025

分析國產人工智能 DeepSeek 的優與劣及其競爭力 - Yahoo 財經

Feb 03, 2025
pulisher
Jan 30, 2025

Telix Pharmaceuticals acquires ImaginAb assets and technology - Investing.com

Jan 30, 2025
pulisher
Jan 27, 2025

Telix Pharmaceuticals Acquires RLS USA in Major $230M Radiopharmacy Network Deal - Stock Titan

Jan 27, 2025
pulisher
Jan 22, 2025

ImaginAb Sells Therapeutic Pipeline to Telix Pharmaceuticals, Focuses on CD8 ImmunoPET Development - Stock Titan

Jan 22, 2025
pulisher
Jan 16, 2025

Telix Pharmaceuticals Secures European Approval for Breakthrough Prostate Cancer Imaging Agent Illuccix - Stock Titan

Jan 16, 2025
pulisher
Jan 13, 2025

Telix Pharmaceuticals Hits Record $517M Revenue, Up 55% as Cancer Imaging Portfolio Expands - Stock Titan

Jan 13, 2025
pulisher
Jan 12, 2025

Telix Pharmaceuticals Acquires ImaginAb's Cancer Drug Pipeline in $45M Strategic Deal - StockTitan

Jan 12, 2025
pulisher
Jan 08, 2025

ASX December health sector winners… and a 91pc drop for a trial-flopped stock - Stockhead

Jan 08, 2025
pulisher
Jan 02, 2025

勞力士據報因材料及勞動力成本上漲 加價最多8% - Yahoo 財經

Jan 02, 2025
pulisher
Dec 31, 2024

ASX healthcare 2024 winners and losers, plus what’s next for 2025 - Stockhead

Dec 31, 2024
pulisher
Dec 17, 2024

本田及日產確認研究合併可能性 日產股價急彈24% - Yahoo 財經

Dec 17, 2024
pulisher
Dec 16, 2024

無人機技術公司Red Cat(RCAT.US)股價漲18% 將與Palantir(PLTR.US)合作 - Yahoo 財經

Dec 16, 2024
pulisher
Dec 10, 2024

信德(00242.HK)附屬向合資公司提供最多1.08億元額外股東貸款 - Yahoo 財經

Dec 10, 2024
pulisher
Dec 03, 2024

Clayton Utz M&A partner Niro Ananda set to resign; KWM eyed - The Australian Financial Review

Dec 03, 2024
pulisher
Nov 27, 2024

Health Check: ASX sleep company emerges from slumber with a revenue and earnings upgrade - Stockhead

Nov 27, 2024
pulisher
Nov 25, 2024

川普貿易戰風險再起 中國買家加緊採購價格低廉的巴西大豆 - Yahoo 財經

Nov 25, 2024
pulisher
Nov 22, 2024

〈熱門股〉正崴切入BBU 股價直奔漲停創4個月高 - Yahoo 財經

Nov 22, 2024
pulisher
Nov 15, 2024

UBS bullish on Telix stock—Illuccix growth & therapeutic expansion fuel upside - Investing.com

Nov 15, 2024
pulisher
Nov 14, 2024

Key Investors Say Bet on These Stocks at Sohn Australia Conference - BNN Bloomberg

Nov 14, 2024
pulisher
Nov 13, 2024

TLXTelix Pharmaceuticals Ltd ADR Latest Stock News & Market Updates - Stock Titan

Nov 13, 2024
pulisher
Nov 13, 2024

Telix Pharmaceuticals Debuts on Nasdaq Global Select Market Under TLX Symbol - Stock Titan

Nov 13, 2024
pulisher
Nov 12, 2024

國際|美國NBC發表「香港領導人警告特朗普」報道 - Yahoo 財經

Nov 12, 2024
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):